Being out of the lab was not easy for us, missing our pipettes and microdevices. But the team never stopped working during the Covid19 crisis! We refined our business plan and invested time in learning and training. But also contributed to scientific dissemination. Here is our CSO, Giustina, talking about how MERYLO’ will revolutionize the chemotherapy.
